A brief adherence intervention that improved glycemic control: mediation by patterns of adherence

Journal of Behavioral Medicine

Volumn 38, Issue 1, 2015, Pages 39-47

  de Vries McClintock, Heather F ^a,b   Morales, Knashawn H ^c   Small, Dylan S ^b   Bogner, Hillary R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Adherence; Mediation; Primary health care; Randomized controlled trials; Type 2 diabetes

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; AGED; BLOOD; CONTROLLED STUDY; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; MEDICATION COMPLIANCE; METABOLISM; MIDDLE AGED; PSYCHOLOGICAL MODEL; PSYCHOLOGY; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MODELS, PSYCHOLOGICAL; PSYCHOTHERAPY, BRIEF;

EID: 84939894222     PISSN: 01607715     EISSN: 15733521     Source Type: Journal    
DOI: 10.1007/s10865-014-9576-3     Document Type: Article

References (47)

1. Aliha, J. M., Asgari, M., Khayeri, F., Ramazani, M., Farajzadegan, Z., & Javaheri, J. (2013). Group education and nurse-telephone follow-up effects on blood glucose control and adherence to treatment in type 2 diabetes patients. International Journal of Preventive Medicine,4(7), 797–802.
2. Almirall, D., Compton, S. N., Gunlicks-Stoessel, M., Duan, N., & Murphy, S. A. (2012). Designing a pilot sequential multiple assignment randomized trial for developing an adaptive treatment strategy. Statistics in Medicine,31(17), 1887–1902.
3. American Diabetes Association. (2014). Clinical practice recommendations. Diabetes Care, 37(Supplement 1), S5–S155.
4. Baron, R. M., & Kenny, D. A. (1986). The moderator–mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. Journal of Personality and Social Psychology,51(6), 1173–1182.
5. Barrera, M., Strycker, L. A., Mackinnon, D. P., & Toobert, D. J. (2008). Social–ecological resources as mediators of two-year diet and physical activity outcomes in type 2 diabetes patients. Health Psychology,27(2 Suppl), S118–S125.
6. Bogner, H. R., Morales, K. H., de Vries, H. F., & Cappola, A. R. (2012). Integrated management of type 2 diabetes mellitus and depression treatment to improve medication adherence: A randomized controlled trial. The Annals of Family Medicine,10(1), 15–22.
7. Brega, A. G., Ang, A., Vega, W., Jiang, L., Beals, J., Mitchell, C. M., et al. (2012). Mechanisms underlying the relationship between health literacy and glycemic control in American Indians and Alaska Natives. Patient Education and Counseling,88(1), 61–68.
8. Crum, R. M., Anthony, J. C., Bassett, S. S., & Folstein, M. F. (1993). Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA,269, 2386–2391.
9. de Vries McClintock, H. F., Morales, K. H., Small, D. S., & Bogner, H. R. Patterns of adherence to oral hypoglycemic agents and glucose control among patients with type 2 diabetes mellitus. Behavioral Medicine (in press).
10. Eaton, W. W. (2002). Epidemiologic evidence on the comorbidity of depression and diabetes. Journal of Psychosomatic Research,53(4), 903–906.
11. Elliott, M. R., Gallo, J. J., Ten Have, T. R., Bogner, H. R., & Katz, I. R. (2005). Using a Bayesian latent growth curve model to identify trajectories of positive affect and negative events following myocardial infarction. Biostatistics,6(1), 119–143.
12. Farmer, K. C. (1999). Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clinical Therapeutics,21(6), 1074–1090. (discussion 1073).
13. Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). “Mini-Mental State”: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research,12(3), 189–198.
14. George, C. F., Peveler, R. C., Heiliger, S., & Thompson, C. (2000). Compliance with tricyclic antidepressants: The value of four different methods of assessment. British Journal of Clinical Pharmacology,50, 166–171.
15. Hayes, E. F. (2009). Beyond baron and kenny: Statistical mediation analysis in the new millennium. Communication Monographs,76(4), 408–420.
16. Haynes, R. B., Ackloo, E., Sahota, N., McDonald, H. P., & Yao, X. (2008). Interventions for enhancing medication adherence. Cochrane Database Systematic Review,2, CD000011.
17. Heidenreich, P. A. (2004). Patient adherence: The next frontier in quality improvement. American Journal of Medicine,117(2), 130–132.
18. Jo, B., & Muthen, B. O. (2001). Modeling of intervention effects with noncompliance: A latent variable approach for randomized trials. In G. A. Marcoulides & R. E. Schumacker (Eds.), New developments and techniques in structural equation modeling (pp. 57–87). Mahwah, NJ: Lawrence Erlbaum Associates.
19. Kahn, R., Alperin, P., Eddy, D., Borch-Johnsen, K., Buse, J., Feigelman, J., et al. (2010). Age at initiation and frequency of screening to detect type 2 diabetes: A cost-effectiveness analysis. Lancet,375(9723), 1365–1374.
20. Krupnick, J. L., Sotsky, S. M., Simmens, S., Moyer, J., Elkin, I., Watkins, J., et al. (1996). The role of the therapeutic alliance in psychotherapy and pharmacotherapy outcome: Findings in the National Institute of Mental Health Treatment of Depression Collaborative Research Program. Journal of Consulting and Clinical Psychology,64(3), 532–539.
21. Lenters-Westra, E., & Slingerland, R. J. (2010). Six of eight hemoglobin A1c point-of-care instruments do not meet the general accepted analytical performance criteria. Clinical Chemistry,56(1), 44–52.
22. Lin, J. Y., Ten Have, T. R., Bogner, H. R., & Elliott, M. R. (2007). Baseline patient characteristics and mortality associated with longitudinal intervention compliance. Statistics in Medicine,26(28), 5100–5115.
23. Mackinnon, D. (2008). Introduction to statistical mediation analysis. New York: Psychology Press.
24. MacKinnon, D. P., Krull, J. L., & Lockwood, C. M. (2000). Equivalence of the mediation, confounding and suppression effect. Prevention Science,1(4), 173–181.
25. MacKinnon, D. P., Lockwood, C. M., Hoffman, J. M., West, S. G., & Sheets, V. (2002). A comparison of methods to test mediation and other intervening variable effects. Psychological Methods,7(1), 83–104.
26. McCabe, R., Bullenkamp, J., Hansson, L., Lauber, C., Martinez-Leal, R., Rossler, W., et al. (2012). The therapeutic relationship and adherence to antipsychotic medication in schizophrenia. PLoS One,7(4), e36080.
27. Moridani, M. Y., Verjee, Z., & Allen, L. C. (2003). Analytical evaluation of hemoglobin A(1c) dual kit assay on Bio-Rad Variant II: An automated HPLC hemoglobin analyzer for the management of diabetic patients. Clinical Biochemistry,36(4), 317–320.
28. Mundt, J. C., Clarke, G. N., Burroughs, D., Brenneman, D. O., & Griest, J. H. (2001). Effectiveness of antidepressant pharmacotherapy: The impact of medication compliance and patient education. Depression and Anxiety,13(1), 1–10.
29. Muthen, B. O. (2001). Latent variable mixture modeling. In G. A. Marcoulides & R. E. Schumacker (Eds.), New developments and techniques in structural equation modeling (pp. 1–33). Mahwah, NJ: Lawrence Erlbaum Associates.
30. Muthen, B., Brown, C. H., Masyn, K., Jo, B., Khoo, S. T., Yang, C. C., et al. (2002). General growth mixture modeling for randomized preventive interventions. Biostatistics,3(4), 459–475.
31. Muthén, L. K., & Muthén, B. O. (1998). Mplus users guide (February 2001, Version 2 Ed.), Los Angeles, CA: Muthén & Muthén.
32. Muthen, B. O., & Shedden, K. (1999). Finite mixture modeling with mixture outcomes using the EM algorithm. Biometrics,55, 463–469.
33. Nakonezny, P. A., Byerly, M. J., & Rush, A. J. (2008). Electronic monitoring of antipsychotic medication adherence in outpatients with schizophrenia or schizoaffective disorder: An empirical evaluation of its reliability and predictive validity. Psychiatry Research,157(1–3), 259–263.
34. Osterberg, L., & Blaschke, T. (2005). Adherence to medication. New England Journal of Medicine,353(5), 487–497.
35. Piette, J., Resnicow, K., Choi, H., & Heisler, M. (2013). A diabetes peer support intervention that improved glycemic control: Mediators and moderators of intervention effectiveness. Chronic Illness, 9(4), 258–267.
36. Piette, J. D., Weinberger, M., McPhee, S. J., Mah, C. A., Kraemer, F. B., & Crapo, L. M. (2000). Do automated calls with nurse follow-up improve self-care and glycemic control among vulnerable patients with diabetes? American Journal of Medicine,108(1), 20–27.
37. Preacher, K. J., & Hayes, A. F. (2008). Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behavior Research Methods,40(3), 879–891.
38. Rasmussen, J. N., Chong, A., & Alter, D. A. (2007). Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA,297(2), 177–186.
39. Small, D. S., Joffe, M. M., Lynch, K. G., Roy, J. A., & Russell Localio, A. (2012). Tom Ten Have’s contributions to causal inference and biostatistics: Review and future research directions. Statistics in Medicine. doi:10.1002/sim.5708.
40. Stewart, A. L., Hays, R. D., & Ware, J. E. (1988). The MOS Short-form General Health Survey: Reliability and validity in a patient population. Medical Care,26, 724–735.
41. Stratton, I. M., Adler, A. I., Neil, H. A., Matthews, D. R., Manley, S. E., Cull, C. A., et al. (2000). Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. BMJ,321(7258), 405–412.
42. Sweet, S. N., Fortier, M. S., Guerin, E., Tulloch, H., Sigal, R. J., Kenny, G. P., et al. (2009). Understanding physical activity in adults with type 2 diabetes after completing an exercise intervention trial: A mediation model of self-efficacy and autonomous motivation. Psychology Health and Medicine,14(4), 419–429.
43. Trief, P. M., Izquierdo, R., Eimicke, J. P., Teresi, J. A., Goland, R., Palmas, W., et al. (2013). Adherence to diabetes self care for white, African-American and Hispanic American telemedicine participants: 5 year results from the IDEATel project. Ethnicity and Health,18(1), 83–96.
44. Trief, P. M., Teresi, J. A., Eimicke, J. P., Shea, S., & Weinstock, R. S. (2009). Improvement in diabetes self-efficacy and glycaemic control using telemedicine in a sample of older, ethnically diverse individuals who have diabetes: The IDEATel project. Age and Ageing,38(2), 219–225.
45. Turner, R. C., Cull, C. A., Frighi, V., & Holman, R. R. (1999). Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: Progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA,281(21), 2005–2012.
46. Vanderweele, T. J., & Vansteelandt, S. (2010). Odds ratios for mediation analysis for a dichotomous outcome. American Journal of Epidemiology,172(12), 1339–1348.
47. Vermeire, E., Wens, J., Van Royen, P., Biot, Y., Hearnshaw, H., & Lindenmeyer, A. (2005). Interventions for improving adherence to treatment recommendations in people with type 2 diabetes mellitus. Cochrane Database Systematic Review,2, CD003638.